We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. 53% of patients with an iodinated contrast allergy and ...

CALGARY, ALBERTA - August 25, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC: VYYRF) ("Voyageur" or the "Corporation") is pleased to announce the launch of its U.S.-based iodine ...

CALGARY, Alberta, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM, USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce the fully-integrated iodine business ...

Enables GE Healthcare to secure increasing supply of iodine, a key ingredient for contrast media products used in X-Ray and Computed Tomography (CT) imaging procedures Supports GE Healthcare’s broader ...

Please provide your email address to receive an email when new articles are posted on . Eleven patients reported 22 reactions during intradermal testing. Nine of 11 patients displayed cross-reactivity ...

Iodine-based contrast material injected intravenously to enhance CT images is safe for most patients, according to a study published online in the journal Radiology. Some case reports and ...

Iodine-based contrast material injected intravenously to enhance CT images can be safely used in most patients, according to a study. Of the 80 million or more CT scans performed each year in the ...

Long-term thyroid dysfunction, including hypothyroidism and hyperthyroidism, was rare but significant among recipients of iodinated contrast media. Iodinated contrast media administration carries a ...

People with a history of allergic-like reactions to iodinated contrast media, which is used in a variety of X-ray-based procedures, such as CT and angiography, are susceptible to similar reactions ...

Exposure to iodinated contrast media during imaging procedures is associated with changes in thyroid function, and increased risk of developing hyperthyroidism, according to a new report. "Iodinated ...

Radiologists and clinicians should weigh the relative benefits and risks of using IV contrast in patients with eGFRs less than 30 mL/min/1.73 m2, according to a consensus statement. The National ...